Concepedia

Frantisek Bruha

FB

3

Publications

81

Citations

3

H-Index

2009

Active since

Affiliations

Pilsen Tools (Czechia)(Current)

Frantisek Bruha is an author at Pilsen Tools (Czechia) specializing in cancer therapeutics, lung cancer, and radiation oncology.

Top concepts

Publications per year

2009–2014

3

Publications

3

Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status.

Miloš Pešek, Lucie Benešová, Barbora Belšánová et al. · PubMed · 2009 · 41 citations

, , +12

Clinical significance of hypermethylation status in NSCLC: evaluation of a 30-gene panel in patients with advanced disease.

Miloš Pešek, Marta Kopečková, Lucie Benešová et al. · PubMed · 2011 · 21 citations

Predictive and prognostic significance of sodium levels in patients with NSCLC treated by erlotinib.

Martin Svatoň, Ondřej Fiala, Miloš Pešek et al. · PubMed · 2014 · 19 citations

Rows per page

1–3 of 3